Kyron.bio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 28, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,500,000
Company Info
- Company Description
- Kyron.bio uses the power of glycan alterations to enable improved protein therapies.
- Market
- Biologic drug development
- Location
- Paris, France
- Coinvestors
- HCVC, Verve Ventures, Entrepreneur First, Saras Capital, multiple angel investors